you will watch the video with the link and password that will be provided and create a power point and answer questions as directed.? Direction is attached, pls ?follow dir

APPENDIX E NURU 641 Week 4 Group Assignment

(50 Bonus Points)

Course Learning Objectives: 1 – 7

Purpose: Part of a PMHNP role is to collaborate with other healthcare professionals such as medical providers, Psychiatrists, Therapists, and with other PMHNPs. The purpose of this assignment is to have students get familiar with collaborating with each other to come to the correct diagnosis and create suitable treatment plans to decrease or alleviate the patient’s symptoms.

Directions: 1. Students will form groups of 4-5 students.

2. Each group will notify the instructor of their group members (By week 3).

3. Each group will watch the following video: https://symptommedia.com/training-title-39/.

Username: UMassGlobalPMHNP (case sensitive) Password: UMassGlobal321 (case sensitive)

4. Then each group will create a PowerPoint presentation addressing the following:

a. The DSM-V-TR diagnosis with support

b. Create a treatment plan (psychopharmacology and psychotherapy) for this patient supported by evidence.

i. Be specific with dosages and the kind of therapy needed, supported by evidence.

5. Each student will evaluate each group member using the following document and submit it along with the PowerPoint presentation via the Assignment tab in Blackboard.

Group Member Evaluation

Presenting GROUP: Date:

Names of Group Members:

Content Exemplary (4) Proficient (3) Developing (2) Emerging (1) Not

Completed 0

12.5 10 8 6 0-4

Analyze team member strengths

12.5 points

Exceptionally thorough and insightful analysis of each team member’s strengths with depth and clarity.

Generally clear coverage with significant attempts at insightful analysis of each team member’s strengths and clarity.

Coverage of analysis of each team member’s strengths lacks depth or clarity.

Did not address topic and missed team members.

Not Completed

Analyze team member weaknesses

12.5 points

Exceptionally thorough and insightful analysis of each team member’s weaknesses with depth and clarity.

Generally clear coverage with significant attempts at insightful analysis of each team member’s weaknesses.

Coverage of analysis of each team member’s weaknesses lacks depth or clarity.

Did not address topic and missed team members.

Not Completed

Reviewer:

Presentation Rubric

Presentation Exemplary (4) Proficient (3) Developing (2)

Emerging (1)

Not Completed 0

Organization:

Logical sequence; easily followed

5 points

Clear and concise

Adequate Incomplete or inaccurate

Inappropriate or missing

Not Completed

PPT Appearance:

Clear and professional font and graphics (prn) with correct English and APA format

5 points

Professional appearance with no visible errors

Adequate appearance with minor errors

Irregular font and/or other visible errors

Inappropriate or poor format with obvious errors

Not Completed

Diagnosis

5 points

Accurate, with criteria and supported by evidence

Accurate but not supported by evidence OR inaccurate but supported with evidence

Incomplete or inaccurate

Inappropriate or missing

Not Completed

Psychopharmacology Treatment Plan

5 points

Accurate, specific and supported by evidence

Accurate and specific but not supported by evidence OR inaccurate but supported with evidence OR accurate and supported by evidence but not specific

Incomplete or inaccurate

Inappropriate or missing

Not Completed

Psychotherapy Treatment Plan

Accurate, specific and supported by evidence

Accurate and specific but not supported by evidence

Incomplete or inaccurate

Inappropriate or missing

Not Completed

Presentation Exemplary (4) Proficient (3) Developing (2)

Emerging (1)

Not Completed 0

5 points OR inaccurate but supported with evidence OR accurate and supported by evidence but not specific

Total: /25*

Additional Comments: Please include at least one positive note about this presentation and at least one suggestion for future presentations here.